Moreover, in the context of AD, it was suggested that individuals bearing the IL12RB1 promoter −111T/T polymorphism displayed a reduced IL-12Rβ1 expression that may have led to increased Th2 cytokine production in the skin and contributed to the development of AD and other subsequent allergic diseases. This evidence concerns the gene IL12RB1 and allergic disease.